Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in U.K. subjects: A novel method of detection

Oral Oncology

Volumn 34, Issue 3, 1998, Pages 191-197

  Elamin, F ^a   Steingrimsdottir, H ^a   Wanakulasuriya, S ^a   Johnson, N ^a   Tavassoli, M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Human papillomavirus; Nested PCR; Oral cancer; Virus typing

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; HUMAN; INCIDENCE; MALE; MOUTH CANCER; PRECANCER; PRIORITY JOURNAL; UNITED KINGDOM; VERRUCA VULGARIS; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; TUMOR VIRUS INFECTIONS;

EID: 0032077913     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(97)00081-X     Document Type: Article

References (39)

1. [1] Pisani P, Parkin DM, Ferlay J. Estimates of the wordwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. International Journal of Cancer 1993;55:891-903.
2. [2] Parkin DM, Pisani P, Ferlay J. Etimates of the worldwide incidence of eighteen major cancers in 1985. International Journal of Cancer 1993;54:594-606.
3. [3] Johnson NW. A global view of the epidemiology of oral cancer. In: Johnson MW, editor. Oral Cancer, Vol. 2. Cambridge Press, 1991. p. 3-26.
4. [4] Blot WJ, Mclaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Research 1988;48:3282-3287.
5. [5] Johnson NW, Warnakulasuriya S, Tavassoli M. Hereditary and enviromental risk factors; clinical and laboratory risk markers for head and neck, especially oral, cancer and precancer. European Journal of Cancer Prevention 1991;5:5-17.
6. [6] Warnakulasuriya S, Johnson NW. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. Journal of Oral Pathology and Medicine 1992;21:404-408.
7. [7] Boyle JO, Hakim J, Kock W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Research 1993;53:4477-4480.
8. [8] Ahomadegbe JC, Barrois M, Fogel S, et al. The incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumours and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 1995;10: 1217-1227.
9. [9] Cox LS, Lane DP. Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. BioEssays 1995;17:501-507.
10. [10] Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992;69:1237-1245.
11. [11] De Villers EM. Human pathogenic papillomavirus types: an update. In: Zur Hausen H, editor. Current Topics in Microbiology and Immunology, Vol. 186. Heidelberg: Springer, 1994. p. 1-12.
12. [12] Syrjanen KJ, Gissmann L, Koss LG, editors. Papillomaviruses and Human Disease, Heidelberg: Springer, 1987.
13. [13] Grimmel M, De Villiers EM, Pawlita M, Neumann C, Zur Hausen H. Characterisation of a new human papillomavirus type (HPV41) isolated from disseminated warts and the detection of closely related sequences in some squamous cell carcinomas. International Journal of Cancer 1988;5:5-9.
14. [14] Chang F, Syrjanen S, Kelokoski J, Syrjanen K. Human papillomavirus (HPV) infections and their associations with oral disease. Journal of Oral Pathology and Medicine 1991;20:305-317.
15. [15] Phelps WC, Kenneth A. Antiviral therapy for human papillomavirus rationale and prospects. Annals of Internal Medicine 1995;123:368-382.
16. [16] Woods KV, Shillitoe EJ, Spitz MR, Storthz K. Analysis of human papillomavirus DNA in oral squamous cell carcinomas. Journal of Oral Pathology and Medicine 1993;22:101-108.
17. [17] Mao EJ. Prevelance of human papillomavirus 16 and nucleolar organiser region counts in oral exfoliated cells from normal and malignant epithelia. Oral Surgery Oral Medicine Oral Pathology 1995;80:320-329.
18. [18] Yeudall WA. Human papillomavirus and oral neoplasia. Oral Oncology, European Journal of Cancer 1992;28B:61-66.
19. [19] Park NH, Min BM, Li SL, Haung MZ, Cherrick HM, Doniger J. Immortalisation of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis (Lond.) 1991;12:1627-1631.
20. [20] Sexton CJ, Proby CM, Banks L, et al. Characterisation of factors involved in human papillomavirus type 16-mediated immortalisation of oral keratinocytes. Journal of General Virology 1993;74:755-761.
21. [21] Kim MS, Shin KH, Back JH, Cherrick HM, Park NH. HPV-16, tobacco-specific N-nitrosamine, and N-methyl-N′-nitro-N-nitro-soguanidine in oral carcinogeneis. Cancer Research 1993;53: 4811-4816.
22. [22] Shin K-H, Tannyhill RJ, Liu X, Park NH. Oncogenic transformation of HPV-immortalised human oral keratinocytes is associated with the genetic instability of cells. Oncogene, 1996;12: 1089-1096.
23. [23] Ogura H, Watanabe S, Fukushima K, Masuda Y, Fujiwara T, Yebe Y. Human papillomavirus DNA in squamous cell carcinomas of the respiratory and upper digestive tracts. Japanese Journal of Clinical Oncology 1993;23:221-225.
24. [24] Yeudall WA, Paterson IC, Patel V, Prime SS. Presence of human papillomavirus sequence in tumour-derived human oral keratinocytes expressing mutant p53. Oral Oncology, European Journal of Cancer 1995;2:136-143.
25. [25] Watts SL, Brewer EE, Fry TL. Human papillomavirus DNA types in squamous cell carcinomas of the head and neck. Oral Surgery, Oral Medicine, Oral Pathology 1991;71:701-707.
26. [26] Smith CJ, Pindborg JJ. Histological Grading of Oral Epithelial Atypia by the Use of Photographic Standards. Copenhagen: C. Hamburgers Bogtrykkeri, 1969.
27. [27] Tavassoli M, Steingrimsdottir H, Pierce E, et al. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21. British Journal of Cancer 1996;74:115-119.
28. [28] Kovalic D, Kwak JH, Weisblum B. General-method for direct cloning of DNA fragments generated by the polymerase chainreaction. Nucleic Acids Research 1991;19:4560.
29. [29] Brachman DG, Graves D, Vokes E, et al. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Research 1992;52:4832-4836.
30. [30] Salam M, Rockett J, Morris A. The prevalance of different human papillomavirus types and p53 mutations in laryngeal carcinomas: is there a reciprocal relationship. European Journal of Surgical Oncology 1995;21:290-296.
31. [31] Cruz IB, Snijders PJ, Steenbergen RD, et al. Age-dependence of human papillomavirus DNA present in oral squamous cell carcishy; nomas. Oral Oncology, European Journal of Cancer 1996;32B: 55-62.
32. [32] Maitland NJ, Cox MF, Lynas C, Prime SS, Meanwell CA, Scully C. Detection of human papilloma virus DNA in biopsies of human oral tissue. British Journal of Cancer 1987;56:245-250.
33. [33] Yeudall WA, Campo MS. Human papillomavirus DNA in biopsies of oral tissues. Journal of General Virology 1991;72:173-176.
34. [34] Steenbergen RD, Hermsen MA, Walboomers JM. Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in oral carcinoma and its derivative cell line. Cancer Research 1995;55:5465-5471.
35. [35] Adler-Storthz K, Newland JR, Tessin BA, Yendall WA, Shillitoe EJ. Identification of human papillomavirus types in oral verruca vulgaris. Journal of Oral Pathology 1986;15:230-233.
36. [36] Lawton GM, Thomas SJ, Schonrock J, Monsour FN, Frazer IH. Prevalence of genital human papillomavirus in normal oral mucosa: a comparison of methods for sample collection. Journal of Oral Pathology and Medicine 1992;21:265-269.
37. [37] Ylitalo N, Bergstrom T, Gyllenstein U. Detection of genital human popillomavirus by single-tube nested PCR and type-specific oligonucleotide hybridisation. Journal of Clinical Microbiology 1995;33:1822-1828.
38. [38] Balaram P, Nalinakumari KR, Abraham E, et al. Human papillomavirus in 91 oral cancer from Indian betel quid chewers - high prevalence and multiplicity of infections. International Journal of Cancer 1995;61:450-454.
39. [39] Sugerman PB, Shillitoe EJ. The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. Oral Diseases 1997;3:130-147.